Lowenstein Sandler advised Sonnet BioTherapeutics, while Sullivan & Worcester advised Chardan Capital Markets on the offering. Sonnet BioTherapeutics Holdings, Inc. (Nasdaq: SONN), a clinical-stage company developing...
You must be a Standard 1 Year member to access this content.
Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to Chardan Capital Markets, LLC, acting as the exclusive placement agent. Involved fees earner: Louis...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Chardan Capital Markets and Invest Securities as joint global coordinators and bookrunners in the transaction. GenSight Biologics executed its private placement (PIPE)....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
You must be a Standard 1 Year member to access this content.
Hunter Taubman Fischer & Li represented Chardan Capital Markets in the transaction. Hudson Acquisition I Corp. announced the closing of its initial public offering of 6,000,000 units...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Orchestra BioMed on the deal. Loeb & Loeb LLP served as legal counsel for HSAC2. Latham & Watkins LLP represented the capital...
You must be a Standard 1 Year member to access this content.
Hunter Taubman Fischer & Li represented Chardan on the IPO. Yotta Acquisition Corporation (“YOTA”) announced the closing of its initial public offering of 10,000,000 units. The...
You must be a Standard 1 Year member to access this content.
Hunter Taubman Fischer & Li represented Chardan Capital Markets in the transaction. A SPAC I Acquisition Corp., a British Virgin Islands company incorporated as a blank...
You must be a Standard 1 Year member to access this content.
